Rheolytic pharmacomechanical thrombectomy in experimental chronic deep vein thrombosis: Effect of L-arginine on thrombogenicity and endothelial vasomotor function

World Journal of Surgery

Volumn 31, Issue 4, 2007, Pages 664-675

  Lin, Peter H ^a   Okada, Tamuru ^a   Steinberg, James L ^a   Zhou, Wei ^a   El Sayed, Hosam F ^a   Rawat, Anish ^a   Kougias, Panos ^a   Yao, Qizhi ^a   Chen, Changyi ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ALTEPLASE; ARGININE; BRADYKININ; CALCIMYCIN; NITRATE; NITRIC OXIDE; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL CULTURE; CHEMOLUMINESCENCE; CONFERENCE PAPER; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; ECHOGRAPHY; ENDOTHELIUM CELL; FIBRIN DEPOSITION; FIBRINOLYTIC THERAPY; ILIAC VEIN; ISOTOPE LABELING; NONHUMAN; PHARMACOMECHANICAL THROMBECTOMY; PHLEBOGRAPHY; RANDOMIZATION; RHEOLYTIC THROMBECTOMY; SCANNING ELECTRON MICROSCOPY; SWINE; THERAPY EFFECT; THROMBECTOMY; THROMBOCYTE; THROMBOGENICITY; VASCULAR ENDOTHELIUM; VASCULAR PATENCY; VASOMOTOR REFLEX;

ADENOSINE DIPHOSPHATE; ANGIOGRAPHY; ANIMALS; ARGININE; BRADYKININ; CALCIMYCIN; DISEASE MODELS, ANIMAL; ENDOSONOGRAPHY; ENDOTHELIUM, VASCULAR; MICROSCOPY, ELECTRON, SCANNING; NITROPRUSSIDE; SEROTONIN; SWINE; THROMBECTOMY; VENOUS THROMBOSIS;

EID: 33947634437     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-007-0733-5     Document Type: Conference Paper

References (43)

1. Gupta R, Stouffer GA. Deep venous thrombosis: a review of the pathophysiology, clinical features, and diagnostic modalities. Am J Med Sci 2001;322:358-364.
2. Reinisch JF, Bresnick SD, Walker JW, et al. Deep venous thrombosis and pulmonary embolus after face lift: a study of incidence and prophylaxis. Plast Reconstr Surg 2001;107:1570-1575.
3. Sharafuddin MJ, Sun S, Hoballah JJ, et al. Endovascular management of venous thrombotic and occlusive diseases of the lower extremities. J Vasc Interv Radiol 2003;14:405-423.
4. Bjarnason H, Kruse JR, Asinger DA, et al. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Interv Radiol 1997;8:405-418.
5. Meissner AJ, Misiak A, Huszcza S, Ziemski JM. [Analysis of general and hemorrhagic complications after treatment of acute proximal deep venous thrombosis of the legs treated with anticoagulants, streptokinase and thrombectomy]. Pol Merkuriusz Lek 2000;9:767-771.
6. Meissner MH. Thrombolytic therapy for acute deep vein thrombosis and the venous registry. Rev Cardiovasc Med 2002;3(Suppl 2):S53-S60.
7. Baldwin ZK, Comerota AJ, Schwartz LB. Catheter-directed thrombolysis for deep venous thrombosis. Vasc Endovascular Surg 2004;38:1-9.
8. Semba CP, Razavi MK, Kee ST, et al. Thrombolysis for lower extremity deep venous thrombosis. Tech Vasc Interv Radiol 2004;7:68-78.
9. Semba CP, Dake MD. Catheter-directed thrombolysis for iliofemoral venous thrombosis. Semin Vasc Surg 1996;9:26-33.
10. Barth KH, Gosnell MR, Palestrant AM, et al. Hydrodynamic thrombectomy system versus pulse-spray thrombolysis for thrombosed hemodialysis grafts: a multicenter prospective randomized comparison. Radiology 2000;217:678-684.
11. Allie DE, Hebert CJ, Lirtzman MD, et al. Novel simultaneous combination chemical thrombolysis/rheolytic thrombectomy therapy for acute critical limb ischemia: the power-pulse spray technique. Catheter Cardiovasc Interv 2004;63:512-522.
12. Cynamon J, Stein EG, Dym RJ, et al. A new method for aggressive management of deep vein thrombosis: retrospective study of the power pulse technique. J Vasc Interv Radiol 2006;17:1043-1049.
13. Cho JS, Martelli E, Mozes G, et al. Effects of thrombolysis and venous thrombectomy on valvular competence, thrombogenicity, venous wall morphology, and function. J Vasc Surg 1998;28:787-799.
14. Lin PH, Johnson CK, Pullium JK, et al. L-arginine improves endothelial vasoreactivity and reduces thrombogenicity after thrombolysis in experimental deep venous thrombosis. J Vasc Surg 2003;38:1396-1403.
15. Lin PH, Surowiec SM, Conklin B, et al. An endovascular model of carotid stenosis for the evaluation of thrombolysis and angioplasty. J Endovasc Ther 2000;7:486-493.
16. Lin PH, Chen C, Surowiec SM, et al. Evaluation of thrombolysis in a porcine model of chronic deep venous thrombosis: an endovascular model. J Vasc Surg 2001;33:621-627.
17. Bush RL, Lin PH, Bates JT, et al. Pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis: safety and feasibility study. J Vasc Surg 2004;40:965-970.
18. Yao SK, Ober JC, Krishnaswami A, et al. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation 1992;86:1302-1309.
19. Yao SK, Akhtar S, Scott-Burden T, et al. Endogenous and exogenous nitric oxide protect against intracoronary thrombosis and reocclusion after thrombolysis. Circulation 1995;92:1005-1010.
20. Surowiec SM, Conklin BS, Li JS, et al. A new perfusion culture system used to study human vein. J Surg Res 2000;88:34-41.
21. Conklin BS, Surowiec SM, Ren Z, et al. Effects of nicotine and cotinine on porcine arterial endothelial cell function. J Surg Res 2001;95:23-31.
22. Chen C, Conklin BS, Ren Z, Zhong D. Homocysteine decreases endothelium-dependent vasorelaxation in porcine arteries. J Surg Res 2002;102:22-30.
23. Rhodes JM, Cho JS, Gloviczki P, et al. Thrombolysis for experimental deep venous thrombosis maintains valvular competence and vasoreactivity. J Vasc Surg 2000;31:1193-1205.
24. Chen C, Mattar SG, Lumsden AB. Oral administration of L-arginine reduces intimal hyperplasia in balloon-injured rat carotid arteries. J Surg Res 1999;82:17-23.
25. Chen C, Lumsden AB, Hanson SR. Local infusion of heparin reduces anastomotic neointimal hyperplasia in aortoiliac expanded polytetrafluoroethylene bypass grafts in baboons. J Vasc Surg 2000;31:354-363.
26. Ouriel K. Comparison of safety and efficacy of the various thrombolytic agents. Rev Cardiovasc Med 2002;3(Suppl 2):S17-S24.
27. Kasirajan K, Gray B, Ouriel K. Percutaneous AngioJet thrombectomy in the management of extensive deep venous thrombosis. J Vasc Interv Radiol 2001;12:179-185.
28. Deitcher SR, Jaff MR. Pharmacologic and clinical characteristics of thrombolytic agents. Rev Cardiovasc Med 2002;3(Suppl 2):S25-S33.
29. Silva JA, Ramee SR, Cohen DJ, et al. Rheolytic thrombectomy during percutaneous revascularization for acute myocardial infarction: experience with the AngioJet catheter. Am Heart J 2001;141:353-359.
30. Lee MS, Singh V, Wilentz JR, Makkar RR. AngioJet thrombectomy. J Invasive Cardiol 2004;16:587-591.
31. Radomski MW, Vallance P, Whitley G, et al. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovasc Res 1993;27:1380-1382.
32. Miller VM, Barber DA. Modulation of endothelium-derived nitric oxide in canine femoral veins. Am J Physiol 1996;271:H668-H673.
33. Ignarro LJ, Napoli C, Loscalzo J. Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. Circ Res 2002;90:21-28.
34. Ruschitzka FT, Wenger RH, Stallmach T, et al. Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci USA 2000;97:11609-11613.
35. Ignarro LJ, Napoli C. Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis. Curr Atheroscler Rep 2004;6:281-287.
36. Fleming I, Busse R. NO: the primary EDRF. J Mol Cell Cardiol 1999;31:5-14.
37. Willerson JT, Igo SR, Yao SK, Ferguson JJ, et al. Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries. Tex Heart Inst J 1996;23:1-8.
38. Ignarro LJ, Cirino G, Casini A, Napoli C. Nitric oxide as a signaling molecule in the vascular system: an overview. J Cardiovasc Pharmacol 1999;34:879-886.
39. Kashyap VS, Reil TD, Moore WS, et al. Acute arterial thrombosis causes endothelial dysfunction: a new paradigm for thrombolytic therapy. J Vasc Surg 2001;34:323-329.
40. Davis MR, Ortegon DP, Kerby JD, et al. Endothelial dysfunction after arterial thrombosis is ameliorated by L-arginine in combination with thrombolysis. J Vasc Interv Radiol 2003;14:233-239.
41. Manicone JA, Eisenbud DE, Hertz SM, et al. The effect of thrombus on the vascular endothelium of arterialized vein grafts. Am J Surg 1996;172:163-166.
42. Rose DA, Hertz SM, Eisenbud DE, et al. Endothelial cell adaptation to chronic thrombosis. Am J Surg 1997;174:210-213.
43. Semba CP, Weck S, Razavi MK, et al. Characterization of alteplase (tPA) following delivery through the AngioJet rheolytic catheter. J Endovasc Ther 2005;12:123-128.